News & Events

HTG Molecular Diagnostics’ & QIAGEN Scientific Symposium

This no-fee Symposium brings together key molecular and pharma professionals for the opportunity to network, discuss noteworthy and trending topics and exchange information in the fields of immuno-oncology and companion diagnostics.  

Who should attend?

  • Thought leaders who look forward to sharing new ideas and solid science that will move pathology and oncology forward.
  • Pathologists who strive to keep their practice on the leading edge with the newest knowledge and technologies.
  • Translational or clinical development within pharma.

Hot Topics

  • Next-Generation Immuno-Oncology Therapeutics
  • Emerging Biomarkers
  • New Applications of Gene Expression Profiling for Clinical Testing
  • New Treatment Strategies

Monday, March 20, 2017 - Dinner
Tuesday, March 21, 2017 - Symposium
Hotel Marriott Rive Gauche
Paris, France

Confirmed Speakers:

Tuesday, March 21, 2017

Dr. Pierre Saintignym, Center Léon Bérard, France

Integrating The Immune Microenvironment And Cancer Cell Plasticity In The Era Of Precision Medicine In Oncology

Prof. Peter Wild, Institute of Pathology and Molecular Pathology, University of Zürich, Switzerland

MicroRNAs In Serum Of Patients With Testicular Germ Cell Tumors Using A Novel Targeted Multiplex Sequencing Assay

Dr. Patrick Micke, Department of Pathology, Uppsala University Hospital, Sweden

Beyond Targeted Therapy: The Immune Landscape Of Human Lung Cancer

Dr. Jose Antonio Lopez, Instituto Valenciano de Oncología, Spain

The Role Of The HTG Edgeseq System In mRNA Pro ling For Therapeutic Decision Making: The Soft Tissue Sarcoma And Breast Cancer Scenarios


Sample To Insight: The Complete Clinical NGS Workflow

Prof. Carsten Denkert, Institut für Pathologie, Charite Hospital, Germany

mRNA Biomarker In FFPE Tissue – New Approaches To Immuno-Oncology In Breast Cancer

Dr. Lakis Liloglou, University of Liverpook, UK

Epigenetic Profiling Of Extracellular Vesicles (EVS) In Early Diagnosis Of Lung Cancer

Dr. Sharon Barrans, The Leeds Teaching Hospital, UK

Molecular Classification Of Aggressive Lymphomas

Start Date: 

Monday, March 20, 2017 to Tuesday, March 21, 2017

Event Location: 

Paris, France

Posted on:

Return To List

Page last updated February 23, 2018